Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Seminars in Oncology|December 1, 1995
Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancerG BolisEuropean Journal of Cancer (Oxford, England : 1990)|April 1, 1997
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, F Zanaboni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.Journal of Computer-Aided Molecular Design|December 1, 1991
A machine learning approach to computer-aided molecular designG Bolis, L Di Pace, F FabrociniJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinomaC Lavarino, S Pilotti, M Oggionni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.The Journal of Reproductive Medicine|October 1, 1993
Multifocal endometriosis. A case reportP Vercellini, N Vendola, M Presti, et al.Biopolymers|June 1, 1997
NMR solution structure of a novel hirudin variant HM2, N-terminal 1-47 and N64-->V + G mutantG Nicastro, L Baumer, G Bolis, et al.Critical Reviews in Oncology/Hematology|February 13, 2001
Role of secondary surgery in relapsed ovarian cancerF Parazzini, F Raspagliesi, P Guarnerio, et al.Cancer Treatment Reports|August 1, 1979
Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycinG Bolis, M D'Incalci, C Belloni, et al.Pageof 11